Anakinra utilization in refractory pediatric CAR T-cell associated toxicities

Blood Adv. 2022 Jun 14;6(11):3398-3403. doi: 10.1182/bloodadvances.2022006983.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Intramural

MeSH terms

  • Child
  • Humans
  • Immunotherapy, Adoptive
  • Interleukin 1 Receptor Antagonist Protein* / therapeutic use
  • Receptors, Chimeric Antigen*
  • T-Lymphocytes

Substances

  • Interleukin 1 Receptor Antagonist Protein
  • Receptors, Chimeric Antigen